Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
Eur J Clin Pharmacol ; 67(10): 1007-16, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21494766

RESUMO

PURPOSE: The objective of this study was to determine whether the so-called "shift" or "drift" problem might occur when generic anti-epileptic drugs are interchanged, and thus to assess if generic anti-epileptic drugs are interchangeable and can be used in an efficacious and safe way on the basis of their bioequivalence to one and the same reference product. METHODS: The bioequivalence of topiramate and gabapentin generics was evaluated. For proper interstudy comparison, individual exposure data (AUC and C(max)) for each bioequivalence study present in the registration dossier was normalized based on the absolute exposure data of one of two innovators. The exposure-normalized plasma concentration curves of the generic product arms between studies were compared, providing indirect evidence of bioequivalence of the different generics. Additionally, comparisons were made for generic-generic as well as innovator-innovator exchange based on absolute exposure data from individual bioequivalence studies. RESULTS: In almost all cases, estimated 90% confidence intervals of the AUC and C(max) ratios for generic-generic interchange were within the routine 80-125% criterion. When absolute, non-corrected exposure data were used for this interstudy comparison, in a number of cases 90% confidence intervals outside the 80-125% criterion were found upon interchanging generics from two studies. However, a similar pattern of 90% confidence intervals outside the 80-125% criterion was observed for the comparison of innovator arms, despite the fact that the innovator was identical in all studies. CONCLUSION: Our results strongly indicate that the so-called drifting problem upon generic-generic substitution does not result in important differences in exposure upon exchanging topiramate generics or gabapentin generics.


Assuntos
Aminas/farmacocinética , Anticonvulsivantes/farmacocinética , Ácidos Cicloexanocarboxílicos/farmacocinética , Medicamentos Genéricos/farmacocinética , Frutose/análogos & derivados , Ácido gama-Aminobutírico/farmacocinética , Aminas/administração & dosagem , Aminas/sangue , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/sangue , Área Sob a Curva , Intervalos de Confiança , Ácidos Cicloexanocarboxílicos/administração & dosagem , Ácidos Cicloexanocarboxílicos/sangue , Interações Medicamentosas , Medicamentos Genéricos/administração & dosagem , Frutose/administração & dosagem , Frutose/sangue , Frutose/farmacocinética , Gabapentina , Humanos , Fatores de Risco , Segurança , Equivalência Terapêutica , Topiramato , Ácido gama-Aminobutírico/administração & dosagem , Ácido gama-Aminobutírico/sangue
2.
J Microbiol Methods ; 105: 51-3, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25043843

RESUMO

We describe a simple device for the aseptic collection of environmental water samples at high spatial resolution to depths of 50m. To demonstrate the utility of this technique we present geochemical and archaeal community data from samples collected throughout the water column of a stratified lake.


Assuntos
Archaea/isolamento & purificação , Técnicas Microbiológicas/instrumentação , Técnicas Microbiológicas/métodos , Microbiologia da Água
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA